Examination of association with candidate genes for diabetic nephropathy in a mexican american population

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 6, 2010, Pages 1072-1078

  Kim, Sulgi ^a   Abboud, Hanna E ^b   Pahl, Madeleine V ^c   Tayek, John ^d   Snyder, Susan ^d   Tamkin, James ^e   Alcorn Jr , Harry ^f   Ipp, Eli ^d   Nast, Cynthia C ^d   Elston, Robert C ^a   Iyengar, Sudha K ^a   Adler, Sharon G ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e Providence Medical Institute   (United States)

^f DAVITA CLINICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 HEREMANS SCHMID GLYCOPROTEIN; CARNOSINE DIPEPTIDASE 1; CASPASE 12; CASPASE 3; CELL PROTEIN; COMPLEMENT FACTOR H; DIPEPTIDASE; GLYCOPROTEIN; HEAT SHOCK 70 KD PROTEIN 1A; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; HEMICENTIN 1; PROTEIN ENGULFMENT AND CELL MOTILITY 1; SCLEROPROTEIN; UNCLASSIFIED DRUG; CNDP1 PROTEIN, HUMAN; ELMO1 PROTEIN, HUMAN; HMCN1 PROTEIN, HUMAN; IMMUNOGLOBULIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HAPLOTYPE; HISPANIC; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MEXICAN AMERICAN; MULTICENTER STUDY; PEDIGREE; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UNITED STATES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETIC NEPHROPATHIES; DIPEPTIDASES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IMMUNOGLOBULINS; LOGISTIC MODELS; MEXICAN AMERICANS; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 77953319102     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06550909     Document Type: Article

References (24)

1. U.S. Renal Data System: 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
2. Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Yard BA, van der Woude FJ, Bowden DW: A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transplant 22: 1131-1135, 2007
3. Leak TS, Perlegas PS, Smith SG, Keene KL, Hicks PJ, Langefeld CD, Mychaleckyj JC, Rich SS, Kirk JK, Freedman BI, Bowden DW, Sale MM: Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann Hum Genet 73: 152-159, 2009
4. Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer E, Baelde H, Bakker SJ, Zirie M, Rondeau E, Mathieson P, Saleem MA, Meyer J, Koppel H, Sauerhoefer S, Bartram CR, Nawroth P, Hammes HP, Yard BA, Zschocke J, van der Woude FJ: Carnosine as a protective factor in diabetic nephropathy: Association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54: 2320-2327, 2005
5. Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, Tsunoda T, Koya D, Babazono T, Tanaka Y, Matsuda M, Kawai K, Iiizumi T, Imanishi M, Shinosaki T, Yanagimoto T, Ikeda M, Omachi S, Kashiwagi A, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Nakajima M, Nakamura Y, Maeda S: Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 54: 1171-1178, 2005 (Pubitemid 40446333)
6. Thompson CL, Klein BE, Klein R, Xu Z, Capriotti J, Joshi T, Leontiev D, Lee KE, Elston RC, Iyengar SK: Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. Hum Mol Genet 16: 2135-2148, 2007
7. Andersen G, Burgdorf KS, Sparso T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O: AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: Studies of metabolic traits in 7,683 white Danish subjects. Diabetes 57: 1427-1432, 2008
8. Zhou H, Pisitkun T, Aponte A, Yuen PST, Hoffert JD, Yasuda H, Hu X, Chawla L, Shen RF, Knepper MA, Star RA: Exosomal fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int 70: 1847-1857, 2006
9. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J, Gupta A, Norris K, Ketteler M, Adler S: Serum fetuin-A in nondialyzed patients with diabetic nephropathy: Relationship with coronary artery calcification. Kidney Int 67: 1070-1077, 2005
10. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 361: 827-833, 2003
11. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU: Alpha2 Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29: 853-857, 2006
12. Lee JW, Kwak HJ, Lee JJ, Kim YN, Lee JW, Park MJ, Jung SE, Hong SI, Lee JH, Lee JS: HSP27 regulates cell adhesion and invasion via modulation of focal adhesion kinase and MMP-2 expression. Eur J Cell Biol 87: 377-387, 2008
13. Garrido C: Size matters: of the small HSP27 and its large oligomers. Cell Death Differ 9: 483-485, 2002
14. Gherardi R, Belghiti-Deprez D, Hirbec G, Bouche P, Weil B, Lagrue G: Focal glomerulosclerosis associated with Charcot-Marie-Tooth disease. Nephron 40: 357-361, 1985 (Pubitemid 15051771)
15. Agarwal A, Nick HS: Renal response to tissue injury lessons from heme oxygenase-1 gene ablation and expression. Am Soc Nephrol 11: 965-973, 2000 (Pubitemid 30241733)
16. Calabrese V, Mancuso C, Sapienza M, Puleo E, Calafato S, Cornelius C, Finocchiaro M, Mangiameli A, Di Mauro M, Stella AM, Castellino P: Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12: 299-306, 2007
17. Kumar D, Robertson S, Burns KD: Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem 259: 67-70, 2004
18. Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MAF, Zeier M, Blessing E, Oh J: Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 13: 1349-1358, 2007
19. Kaufman RJ: Orchestrating the unfolded protein response in health and disease. Am Soc Clin Investig 110: 1389-1398, 2002
20. Knowler WC, Coresh J, Elston RC, Freedman BI, Iyengar SK, Kimmel PL, Olson JM, Plaetke R, Sedor JR, Seldin MF: The Family Investigation of Nephropathy and Diabetes (FIND): Design and methods. J Diabetes Complications 19: 1-9, 2005
21. Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, Ipp E, Kao WH, Kimmel PL, Klag MJ, Knowler WC, Meoni LA, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Quade SR, Rich SS, Rotter JI, Scavini M, Schelling JR, Sedor JR, Sehgal AR, Shah VO, Smith MW, Taylor KD, Winkler CA, Zager PG, Freedman BI: Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: The Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 56: 1577-1585, 2007
22. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D: Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909, 2006
23. Kim S, Morris NJ, Won S, Elston RC: Single-marker and two-marker association tests for unphased case-control genotype data, with a power comparison. Genet Epidemiol 34: 67-77, 2010
24. Schultz DW, Weleber RG, Lawrence G, Barral S, Majewski J, Acott TS, Klein ML: HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease: Review and perspective. Ophthalmic Genet 26: 101-105, 2005